Matthew Hewitt

Matthew Hewitt is a seasoned professional with vast research experience in target & drug discovery, in vivo/in vitro model & assay development, tumor immunology/microenvironment, autologous/allogeneic/syngeneic rodent oncology models, CAR T-cells, AAV gene therapy/immunology, bioengineering, upper airway physiology, and neurobiology. With over 15 years of experience, he has authored numerous manuscripts, technical papers, and abstracts for high impact journals and presented data at national and international meetings. Matthew has a strong managerial background, with over 10 years of experience mentoring junior staff. He also possesses regulatory expertise, having written reports for FDA and European Medical Authority filings as well as patents in the US and EU.